Geneos Wealth Management’s FlexShares Credit-Scored US Corporate Bond Index Fund SKOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$84.7K Buy
1,742
+13
+0.8% +$637 ﹤0.01% 1227
2025
Q4
$84.9K Sell
1,729
-4,395
-72% -$216K ﹤0.01% 1202
2025
Q3
$302K Buy
+6,124
New +$299K 0.01% 782

Other funds holding SKOR

Geneos Wealth Management's SKOR Position: Q1 2026 in Review

Geneos Wealth Management increased its FlexShares Credit-Scored US Corporate Bond Index Fund (SKOR) stake by 0.75% in Q1 2026, buying an estimated $637 and bringing the position to 1,742 shares worth $84.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1227.

Geneos Wealth Management first reported a position in SKOR in Q3 2025 and has held it in 3 quarters since. The position peaked at $302K in Q3 2025. 65 funds tracked by Wall St. Rank hold SKOR as of Q1 2026.

  • Geneos Wealth Management held 1,742 shares of FlexShares Credit-Scored US Corporate Bond Index Fund worth $84.7K as of Q1 2026.
  • Geneos Wealth Management bought 13 FlexShares Credit-Scored US Corporate Bond Index Fund shares in Q1 2026, an estimated $637.
  • FlexShares Credit-Scored US Corporate Bond Index Fund made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #1227 holding.
  • Geneos Wealth Management first reported a position in FlexShares Credit-Scored US Corporate Bond Index Fund in Q3 2025 and has held it in 3 quarters since.
  • Geneos Wealth Management's FlexShares Credit-Scored US Corporate Bond Index Fund position peaked at $302K in Q3 2025.
  • 65 funds tracked by Wall St. Rank held FlexShares Credit-Scored US Corporate Bond Index Fund as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.